EW:NYSE
Edwards Lifesciences Corp
107,15 US$
arrow_upward
+1,19%(+1,26) 1K
13-noy, 16:00:04 (GMT-5) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEW tikeri uchun statistika yaratilmoqda...
Ochish
106,10 US$
Yuqori
107,69 US$
Past
106,01 US$
Bozor kapitali
61,61 mlrd
Oʻrtacha hajm
4,51 mln
Hajmi
803,00
P/E koeffitsiyenti
60,75
52 haftalik eng yuqori
107,69 US$
52 haftalik eng past
74,66 US$
Aksiya boʻyicha daromad
1,76 US$
Beta
0,85
Muomaladagi aksiyalar
575,00 mln
Xodimlar soni
16 ming
Ochish
106,10 US$
Yuqori
107,69 US$
Past
106,01 US$
Bozor kapitali
61,61 mlrd
Oʻrtacha hajm
4,51 mln
Hajmi
803,00
P/E koeffitsiyenti
60,75
52 haftalik eng yuqori
107,69 US$
52 haftalik eng past
74,66 US$
Aksiya boʻyicha daromad
1,76 US$
Beta
0,85
Muomaladagi aksiyalar
575,00 mln
Xodimlar soni
16 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Traders Union
·
1 kun oldin
MarketWise: Edwards Lifesciences revenue climbs 10.5 percent, earnings surge 19 percent
Trefis
·
2 kun oldin
Is There Any Reason To Invest In Edwards Lifesciences Stock?
Profil
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
Edwards Lifesciences Corp haqida
CEO-
Xodimlar soni16 ming
Asos solingan1958
Bosh ofislarIrvayn, Kaliforniya, Amerika Qo‘shma Shtatlari
SektorHealth Care
Soha-
Veb-saytedwards.com